Litcius/Paper detail

Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial

Guy Young, Alok Srivastava, Kaan Kavaklı, Cecil Ross, Jameela Sathar, Chur-Woo You, Huyen Tran, Jing Sun, Runhui Wu, Stacey Poloskey, Zhiying Qiu, Salim Kichou, Shauna Andersson, Baisong Mei, Savita Rangarajan

2023The Lancet122 citationsDOI

Topics & Concepts

HaemophiliaMedicineOpen labelHaemophilia AClinical trialAtlas (anatomy)Internal medicinePediatricsAnatomyHemophilia Treatment and ResearchBlood Coagulation and Thrombosis MechanismsNeurogenetic and Muscular Disorders Research
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial | Litcius